Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steward

Showing results (151-160 of 256) with videos related to

Pageof 26
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 26, 2001
Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agentsS M Plummer, K A Hill, M F Festing, et al.
British Journal of Cancer|June 27, 2002
A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancerK J O'Byrne, A L Thomas, R A Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1990
Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group StudyG Blackledge, A van Oosterom, H Mouridsen, et al.
Rapid Communications in Mass Spectrometry : RCM|June 24, 2011
Evaluation of urinary ribonucleoside profiling for clinical biomarker discovery using constant neutral loss scanning liquid chromatography/tandem mass spectrometryFriederike Teichert, Swantje Winkler, Hector C Keun, et al.
Biomedical Chromatography : BMC|September 3, 2010
Determination of anthocyanins in the urine of patients with colorectal liver metastases after administration of bilberry extractHong Cai, Sarah C Thomasset, David P-Berry, et al.
Ciba Foundation Symposium|January 1, 1990
Growth factor-assisted chemotherapy--the Manchester experienceD Crowther, J H Scarffe, A Howell, et al.
Journal of Agricultural and Food Chemistry|April 5, 2007
Breast cancer prevention by green tea catechins and black tea theaflavins in the C3(1) SV40 T,t antigen transgenic mouse model is accompanied by increased apoptosis and a decrease in oxidative DNA adductsSiminder Kaur, Peter Greaves, Darren N Cooke, et al.
Cancer|September 15, 1985
Three months' treatment with cyclophosphamide, VP-16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancerN Thatcher, R D James, W P Steward, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategiesS K Pathak, R A Sharma, W P Steward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosisA G Kamthan, M J Lind, N Thatcher, et al.
Pageof 26

Showing results (151-160 of 256) with videos related to

Sort By:
Pageof 26
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 26, 2001
Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agentsS M Plummer, K A Hill, M F Festing, et al.
British Journal of Cancer|June 27, 2002
A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancerK J O'Byrne, A L Thomas, R A Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1990
Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group StudyG Blackledge, A van Oosterom, H Mouridsen, et al.
Rapid Communications in Mass Spectrometry : RCM|June 24, 2011
Evaluation of urinary ribonucleoside profiling for clinical biomarker discovery using constant neutral loss scanning liquid chromatography/tandem mass spectrometryFriederike Teichert, Swantje Winkler, Hector C Keun, et al.
Biomedical Chromatography : BMC|September 3, 2010
Determination of anthocyanins in the urine of patients with colorectal liver metastases after administration of bilberry extractHong Cai, Sarah C Thomasset, David P-Berry, et al.
Ciba Foundation Symposium|January 1, 1990
Growth factor-assisted chemotherapy--the Manchester experienceD Crowther, J H Scarffe, A Howell, et al.
Journal of Agricultural and Food Chemistry|April 5, 2007
Breast cancer prevention by green tea catechins and black tea theaflavins in the C3(1) SV40 T,t antigen transgenic mouse model is accompanied by increased apoptosis and a decrease in oxidative DNA adductsSiminder Kaur, Peter Greaves, Darren N Cooke, et al.
Cancer|September 15, 1985
Three months' treatment with cyclophosphamide, VP-16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancerN Thatcher, R D James, W P Steward, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategiesS K Pathak, R A Sharma, W P Steward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosisA G Kamthan, M J Lind, N Thatcher, et al.
Pageof 26